Singapore
Health Sciences Authority (HSA) · Asia-Pacific
Executive summary
Singapore is regulated by the Health Sciences Authority (HSA), a statutory board of the Ministry of Health, established in 2001 by the Health Sciences Authority Act. HSA operates under the Health Products Act 2007 and the Medicines Act 1975 and regulates therapeutic products, medical devices, IVDs, cosmetics, complementary medicines, cell/tissue/gene therapies, blood products, and tobacco. Singapore is one of the most reliance-friendly markets globally. HSA was a founding member of the ACCESS Consortium (with TGA, Health Canada, Swissmedic, MHRA — work-sharing on new drug evaluations) and operates four routes calibrated to the level of foreign approval: Full Evaluation, Abridged, Verification, and Post-Approval. The Verification route accepts approval by 1 reference agency and is the fastest at 60–120 days. Singapore is a PIC/S member, ICH regulatory member, and recognises ICH-CTD/eCTD. Despite a market of only ~5.9M people, Singapore is a strategic regional hub for pharma — many companies use Singapore approval as the entry point for ASEAN. The Agency for Care Effectiveness (ACE) is the HTA body that recommends Standard Drug List (SDL) and Medication Assistance Fund (MAF) listings.
About the authority
HSA is organised into the Health Products Regulation Group (HPRG — therapeutic products, medical devices, complementary medicines, cosmetics), Blood Services Group, and Applied Sciences Group (forensic science). Within HPRG, the Therapeutic Products Branch handles drug registration and the Audit and Licensing Division handles GMP/GDP licensing. HSA operates the PRISM electronic submission portal.
International affiliations
Reliance & recognition
Singapore operates one of the world's most mature reliance frameworks. Three explicit reliance routes (Abridged, Verification, ACCESS) plus reliance for GMP via PIC/S. Choice of route is calibrated by number/identity of foreign approvals and how identical the Singapore product is to the foreign-approved version.